Newsletter Subject

Nonselective Beta-Blockers May Improve Outcomes in Ovarian Cancer

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Tue, Aug 30, 2022 08:07 PM

Email Preheader Text

Oncology Update Tuesday, August 30, 2022 ADVERTISEMENT Exclusives & Features B-cell malignancies, mo

[MEDPAGE TODAY]( Oncology Update Tuesday, August 30, 2022 [Nonselective Beta-Blockers May Improve Outcomes in Ovarian Cancer]( [Can Pre-Op Chemo Set Stage for Organ-Sparing Surgery in Early Rectal Cancer?]( [Pralsetinib Shows Promise in Diverse RET Fusion-Positive Cancers]( [Bispecific Antibody Active in Heavily Treated Multiple Myeloma]( ADVERTISEMENT Exclusives & Features [Children's National Latest Target of Transgender Care Attacks]( [12 People Poisoned at Toronto-Area Restaurant]( [After Months of Improvement, Hospital Financial Performance Takes Another Hit]( [The Safety of Bruton's Tyrosine Kinase Inhibitors in B-cell Malignancies: A Systematic Review.]( B-cell malignancies, most notably lymphomas, make up most of the non-Hodgkin lymphomas in the United States. There is limited randomized data comparing 1st and 2nd generation Bruton Tyrosine Kinase... [READ MORE]( [8 recent moves from the nation's leading cancer centers]( Here are eight moves from leading cancer centers across the nation that Becker's has covered since July 22: [READ MORE]( [From Patient To Policy Insider: Greg Simon’s Cancer Rx Includes A Better White House Rallying Call]( The “Cancer Moonshot” should be renamed “Human Moonshot” as part of a true global effort, Simon tells Forbes China Healthcare Forum [READ MORE]( [When Someone You Love Gets That Dreaded Call]( With one diagnosis life can change forever. Those of us on the sidelines have a new role: supporter. Here are some guidelines to doing that as well as possible. [READ MORE]( [U.S. Cancer Moonshot Needs Stronger Int’l Effort To Make Substantial Progress – Kevin Rudd]( "International trials have been key to accelerating the breakthroughs that we've seen so far," Rudd told the Forbes China Healthcare Summit [READ MORE]( [A Property of Everyday Health group]( © 2022 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2022-08-30&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 345 Hudson Street 16th Floor New York, NY 10014

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.